RankAlpha logo
Back to Rankings

MESO

MesoblastD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MESO vs peer average
30/100
MESO vs. peer average (D vs. C)
Grade spread
A 2 · C 4 · D 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

VERA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.28B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerVERAVera Therapeutics
MESO
Mesoblast
VERA
Vera Therapeutics
Grade
D
A
Momentum
53
23
Value
46
41
Sentiment
-
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs VERA

MESO / VERA
Grade Position
Below peers
MESO vs. peer average (D vs. C)
30/100
Momentum
53
MESO
Value
46
MESO
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MESO
1
VERA
Vera Therapeutics Inc Class A Common
A
100/100
-3
2
NUVB
Nuvation Bio Inc Class A Common
C
60/100
-1
3
HCM
HUTCHMED (China) Ltd ADR
D
40/100
Even
4
VCEL
Vericel Corp Common
C
60/100
-1
5
ALMR
Alamar Biosciences Inc Common
C
60/100
-1
VERA is the first peer returned for this comparison set.